3,795.70
+74.8(+2.01%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
15718
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Mr. Sanjay Gupta | President and Chief Executive Officer of Torrent Pharma USA | 0 | N/A |
| Mr. Sudhir Menon CA, CWA | Executive Director of Finance & Chief Financial Officer | 16.3M | 1972 |
| Mr. Aman Mehta | MD & Whole-Time Director | 75.74M | N/A |
| Mr. Chintan M. Trivedi | Company Secretary & Compliance Officer | 0 | N/A |
| Mr. Abdullah Salam Said Al Abri | Chief Customer Service Officer | 0 | N/A |
| Mr. Ashish Hajarnish M.Pharm | Executive Director of Operations | 0 | 1968 |
| Mr. Jaydip Bhatt | Vice President of Human Resource | 0 | 1953 |
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.